Controls | CRS | CRS-NP | Kruskall Wallis-test | |
---|---|---|---|---|
Eicosanoids | ||||
LTC4/D4/E4 (ng/ml) | 1.16 (IQR: 0.85–1.68) | 3.34 (IQR: 2.70–5.35) | 7.24 (IQR: 4.65–12.40) | P < 0.01 § |
LTB4 (ng/ml) | 25.25 (IQR: 8.26–63.91) | 21.95 (IQR: 9.40–31.90) | 19.44 (IQR: 12.80–29.71) | N.S |
PGE2 (ng/ml) | 180.63 (IQR: 101.44–258.86) | 199.83 (IQR: 59.10–223.52) | 55.00 (IQR: 40.59–67.87) | p = 0.02 ¶ |
Eosinophilic inflammation markers | ||||
ECP (μg/L) | 602.51 (IQR: 309.90–894.30) | 2090.00 (IQR: 1437.60–5442.40) | 11880.00 (IQR: 1862.70–17920.74) | p < 0.01 § |
Sol-IL-5Rα protein (ng/ml) | 20.62 (IQR: 15.77–26.43) | 50.95 (IQR: 28.62–67.78) | 175.24 (IQR: 37.11–309.67) | P < 0.05 § |
sol-IL-5Rα mRNA (pg/μl) | 14757.50 (IQR: 12493.97–23015.35) | 159065.30 (IQR: 45909.00–185796.90) | 458449.55 (IQR: 267447.00–796387.30) | p = 0.02 § |
EG2 positive cells | 1,00 (IQR: 1,00–1,15) | 1,05 (IQR: 1,00–1,40) | 2,10 (IQR: 1,90–2,25) | p < 0.01 ¶ |